Blood cancer patients show widely variable response to COVID-19 vaccines

By | June 28, 2021
Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines–in some cases, no detectable response–pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study that will be published in Cancer Cell this week.